Showing 1 - 10 of 15
Background: Antiplatelet therapy plays a central role in the prevention of atherothrombotic events. Both acetylsalicylic acid (aspirin) and clopidogrel have been shown to reduce the risk of recurrent cardiovascular events in various subgroups of patients with vascular disease. Objective: To...
Persistent link: https://www.econbiz.de/10008462721
Schizophrenia is a chronic disease characterized by periods of relative stability interrupted by acute episodes (or relapses). The course of the disease may vary considerably between patients. Patient histories show considerable inter- and even intra-individual variability. We provide a critical...
Persistent link: https://www.econbiz.de/10005404892
<Emphasis Type="Bold">Background: The PCI-CURE (Percutaneous Coronary Intervention-Clopidogrel in Unstable Angina to Prevent Recurrent Events) and CREDO (Clopidogrel for the Reduction of Events During Observation) studies have demonstrated that, in addition to aspirin, pre-treatment with clopidogrel followed by...</emphasis>
Persistent link: https://www.econbiz.de/10011001669
Findings suggest that EQ-5D utilities or item responses could be estimated on the basis of NP scores. Independent testing of the external validity of the mapping algorithms developed herein is encouraged. </AbstractSection> Copyright Springer International Publishing AG 2012
Persistent link: https://www.econbiz.de/10011277356
Persistent link: https://www.econbiz.de/10009404216
Background: In the Balloon Angioplasty and Anticoagulation Study (BAAS), coumarins added to routine aspirin therapy before coronary angioplasty reduced cardiac events at the cost of a slightly higher risk of bleeding complications. Objective: To determine the cost effectiveness of coumarin...
Persistent link: https://www.econbiz.de/10005449091
Background: A number of new antiepileptic agents have been introduced within a short period of time. Direct comparisons are not available, and information about the balance between costs and effects for these new therapies is lacking. Objective: To introduce a first approximation of the cost...
Persistent link: https://www.econbiz.de/10005404957
The methods that have been used to estimate the clinical and economic impact of vaccination programmes are not always uniform, which makes it difficult to compare results between economic analyses. Furthermore, the relative efficiency of vaccination programmes can be sensitive to some of the...
Persistent link: https://www.econbiz.de/10005590321
Persistent link: https://www.econbiz.de/10005293362
The role of modelling in economic evaluation is explored by discussing, with examples, the uses of models. The expanded use of pragmatic clinical trials as an alternative to models is discussed. Some suggestions for good modelling practice are made. © 1997 by John Wiley & Sons, Ltd.
Persistent link: https://www.econbiz.de/10005199982